HIT Consultant January 23, 2026
Joel Diamond, MD, Co-Founder Chief Medical Officer of Aranscia

Pharmacogenomics, also referred to as PGx, is the use of a patient’s genetic makeup to guide safer, more effective medication choices and dosing in everyday clinical practice, including primary care. Although it has emerged as an essential and evidence-based tool in the primary care toolbox, its widespread adoption remains slow.

After more than 30 years in family medicine, I’ve watched every major clinical innovation face early skepticism – from electronic medical records to laparoscopic and robotic-assisted surgery. Yet here we are, firmly rooted in amazing advances in cancer care, rare disease treatment, and new standards in maternal-fetal medicine—all using genetic insights to help guide care. The future is clearly here, but there still remains doubt in the minds of primary...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Primary care, Provider
Around the nation: Amazon's One Medical launches new AI chatbot
AAP Releases 2026 Child Vax Schedule, No Longer Endorses CDC's Version
Healing chronic illness requires treating the mind alongside the body [PODCAST]
STAT+: How investing in primary care helped a hospital system get back in the black
Why the primary care system failure forces unnecessary referrals

Share Article